Gene Expression Market Size, Share & Trends Report

Gene Expression Market Size, Share & Trends Analysis Report By Process (cDNA Synthesis, PCR Analysis), By Products, By Capacity, By Technique, By Application, By Region, And Segment Forecasts, 2018 - 2025

  • Published Date: Aug, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-576-2
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 185

Report Overview

The global gene expression market size was estimated at USD 6.81 billion in 2016. Gene expression analysis supports cutting-edge research and enables scientific discoveries by providing insights into gene function at molecular levels. Gain or loss of function results in changes in phenotype, intracellular localization, and probable other changes that might have caused the disease. Increased focus on advanced healthcare framework and adoption of advanced technology in modern diagnostics and drug development. These advances are expected to drive revenue generation.

UK gene expression analysis market size

Identification of molecular pathways of drug response and that of pathogenesis have leveraged the drug development and disease modeling sections. The use of gene profiling studies for the development of novel therapeutics have also increased owing to the resultant reduction in turnaround time and cost associated with more efficient results. Rapid diagnostic tests using these systems are available for diseases with symptoms that are either complicated or pose ambiguity with other diseases.

The decline in the cost of genetic sequencing over the past decade has enabled its adoption of clinical applications. Introduction of the Precision Medicine Initiative has accelerated the adoption of advanced technological tools in medicine and similar healthcare initiatives are anticipated to provide lucrative avenues for growth.

Cap Analysis of Gene Expression (CAGE) that allows comprehensive mapping of human transcription start sites and their promoters have been introduced to overcome the limitations of microarrays. It allows the quantification of mRNA sets within a cell. The market witnesses frequent upgrades of products with advances in technology and the introduction of novel techniques or platforms, a factor that is anticipated to drive further development.

The global rise in cancer incidence with an increase in a number of unique cases has become a point of key interest for all healthcare organizations. Tracing the cause to be a mutation in function, studying manifestation patterns of particular genes that would help design precision medicine treatment for cancer patients and help reduce recurrence/relapse rate is another important driver for revenue generation.

Process Insights

The steps involved in the transcription of genes into functional gene products, proteins, and functional RNAs have various commercial implications and thus attract different revenue shares. At various steps along the process information related to normal cellular processes as well as abnormal or pathological pathways is accumulated. A defect in any step from the transcription of DNA code into RNA to the synthesis of protein can lead to the abnormal manifestation of the nucleic acids.

PCR systems have witnessed frequent upgradations with the introduction of RT-PCR and qPCR along with their enhanced versions. PCR analysis is estimated to have the largest revenue share owing to high adoption and introduction of systems integrated with other steps as well as techniques.

Gene manifestation research is useful only with accurate data processing & interpretation. Rise in demand for better analytic tools for genomic studies has encouraged players to invest in the development of this software. Players offering customized services for expression data analysis have entered into the market. Large amounts of “omics” data has been generated over the years post introduction of sequencing technology, thereby accelerating the demand for analytic platforms. Thus, data analysis & interpretation process is estimated to witness rapid growth over the forecast period.

Product Insights

Kits & reagents dominate the gene expression market with the largest revenue share due to the higher usage of these products irrespective of which technique is adopted. Though the prices are comparatively lower, however, the sales volumes are high enough to make these account for a larger share. The launch of novel kits and reagents with enhanced efficiency is projected to drive revenue generation over the forecast period.

Moreover, rising demand for better data interpretation & visualization has encouraged companies to enhance bioinformatics tools and platforms to meet the needs of modern day research. The introduction of platforms that provide simple tools such as topology enrichment and differential co-manifestation research that cater to the specific needs of the end users also constitute a significant section of the product portfolio.

Powerful statistical tools that enable intuitive data analysis and visualization are available. Alignment with NGS data and correlation with other data types with these tools can be used to identify targets of interest. With rise in the number of experts with an integrated knowledge of computation and biotechnology, advances in data analytics and interpretation platforms is expected over the coming years.

Capacity Insights

Advances in stem cell research and genetic engineering with scientists trying to manipulate and control gene expression levels in living systems have promoted the development of low- and mid-plex techniques that use sample size with about 1,000 targets as well as high throughput multiplexing techniques. Rise in the number of research related to single cell analysis, stem cell therapy, regenerative therapy, and cancer genomics, these techniques are anticipated to fuel market growth.

Development of multiplexed digital characterization systems that have spatially resolved solutions that eliminate the need for upfront probe validation has made high-plex techniques simpler with increased accuracy. Screening the whole genome or larger sample sizes for the identification of biomarkers for potential therapies is attributive to the lucrative growth of high-plex capacity techniques.

Technique Insights

PCR analysis and DNA microarrays are well-established techniques that exhibit high adopted by researchers and biologists to study expressions of various genes and microorganisms. Integration of these techniques with others such as immunoprecipitation assay (ChIP-PCR and ChIP-chip) to enhance their performance and suit more specific targeting requirements can be attributed to anticipated further usage potential.

The emergence of next-generation sequencing has revolutionized the various fields of genetics including expression profiling. RNA sequencing offers high precision analysis for sequence data in a broad range from as small as 25 or 30 ng of total RNA to the entire mammalian genome. RNA expression techniques are poised to have significant growth over the forecast period.

Application Insights

High cost and time associated with drug development and its commercial launch have increased the interest of major pharmaceutical players to invest in alternative options that can increase the efficiency of the whole process. Gene expression analysis of cells before and after treatment with the drug under investigation helps accelerate the drug development process.

Furthermore, the associated ability of expression analysis to provide an early and precise diagnosis to predict the occurrence of rare genetic conditions such as early onset infection (EOI) in preterm infants is another key aspect projected to drive adoption of gene expression in clinical diagnostic tests. The integration of bioinformatics and computation algorithms with enhanced platforms for better diagnosis and tracking disease progression would generate lucrative avenues for adoption in clinical testing settings.

Gene expression analysis market share

Regional Insights

North America dominated the global market in 2016 in terms of revenue share. This is due to the presence of a substantial number of well-established players in the region. Increased focus on advanced healthcare, government support to initiatives that promote precision medicine, high investments in genomic research, further contribute to revenue generation.

However, Asia Pacific is projected to witness the fastest growth over the coming years. Changes in government policies of emerging economies that encourage foreign investments along with increased interest from well-established players to capture the untapped market in the region is attributive to developments in this region. In addition, countries such as China and Japan are observed to have a considerable number of private investors entering the gene therapy and related fields which, in turn, is expected to fuel demand for gene expression.

Key Companies & Market Share Insights 

Major entities operating in this market include QIAGEN, Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd, Illumina, Inc., Novogene Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., Promega Corporation, Luminex Corporation, TAKARA BIO INC., and Danaher. The market players are involved in the development of novel kits and reagents to enhance the process of expression analysis.

Furthermore, they are engaged in strategic partnerships to expand their market reach. Key players are also involved in the acquisition of smaller players to enhance the product portfolio. For instance, ThermoFisher acquired Affymetrix, Inc., and Life Technologies Corporation. Another acquisition that was witnessed was of Cepheid by Danaher in 2016.

Gene Expression Market Report Scope

Report Attribute


Market size value in 2020

USD 8.5 billion

Revenue forecast in 2025

USD 11.4 billion

Growth Rate

CAGR of 5.9% from 2017 to 2025

Base year for estimation


Historical data

2014 - 2016

Forecast period

2017 - 2025

Quantitative units

Revenue in USD Million & CAGR from 2017 to 2025

Report coverage

Revenue forecast; company share; competitive landscape; growth factors and trends

Segments covered

Process, product, capacity, technique, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; Japan; China; Brazil; South Africa.

Key companies profiled

QIAGEN, Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd, Illumina, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, GE Healthcare, TAKARA BIO INC.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country; regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the regional & country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this report, Grand View Research has segmented the gene expression market on the basis of process, product, capacity, technique, application, and regions:

  • Process Outlook (Revenue, USD Million; 2014 - 2025)

    • Sample Collection

    • Purification

    • cDNA synthesis & conversion

    • PCR Analysis

    • Data analysis & interpretation

  • Product Outlook (Revenue, USD Million; 2014 - 2025)

    • Kits & Reagents

    • DNA Chips

    • Others

  • Capacity Outlook (Revenue, USD Million; 2014 - 2025)

    • Low- to Mid- Plex

    • High-Plex

  • Technique Category Outlook (Revenue, USD Million; 2014 - 2025)

    • RNA Expression

      • Northern Blotting

      • DNA Microarrays

      • PCR Techniques

      • RNA-Seq

    • Promoter Analysis

      • In vitro Transcription/Nuclear Run-On Assays

      • Gel Shift Assays

      • Chromatin Immunoprecipitation (ChIP)

    • Protein Expression & Posttranslational Modification Analysis

      • Western Blotting

      • 2-D Gel Electrophoresis

      • Immunoassays

      • Mass Spectrometry

  • Application Outlook (Revenue, USD Million; 2014 - 2025)

    • Drug Discovery & Development

    • Clinical Diagnostics

    • Biotechnology & Microbiology

    • Others

  • Regional Outlook (Revenue, USD Million; 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

    • The Middle East and Africa (MEA)

      • South Africa

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities